John F. Crowley - 15 Nov 2021 Form 4 Insider Report for AMICUS THERAPEUTICS, INC. (FOLD)

Role: Chairman & CEO, Director
Signature: /s/ Christian Formica, Attorney-in-Fact
Issuer symbol: FOLD
Transactions as of: 15 Nov 2021
Net transactions value: -$183,736
Form type: 4
Filing time: 17 Nov 2021, 18:30:08 UTC
Previous filing: 03 Nov 2021
Next filing: 04 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FOLD	Common Stock	Options Exercise	$109,215	+24,935	+3%	$4.38	849,461	15 Nov 2021	Direct
transaction	FOLD	Common Stock	Sale	$292,951	-24,935	-2.9%	$11.75	824,526	15 Nov 2021	Direct	F1
holding	FOLD	Common Stock						64,895	15 Nov 2021	By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FOLD	Stock Options (right to buy)	Options Exercise	$0	-24,935	-100%	$0.000000^*	0	15 Nov 2021	Common Stock	24,935	$4.38	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2	All of these options were fully vested and exercisable as of the transaction date.